Scott advises clients across functional areas including Value Pricing and Access Strategy, Commercial Strategy, and Business Analytics.
He has extensive experience working in domestic and international markets across a range of therapeutic areas, including vaccines and infectious disease, hematology / oncology, rare diseases, orthopedics, immunology, renal disorders, and neurology. Recent projects have spanned the product life cycle, focusing on new product development strategy and demand assessment, pricing and contracting, forecasting, customer segmentation and salesforce optimization, and loss of exclusivity planning.
Scott joined Putnam in 2014 after graduating with distinction from Duke University with a B.S. in Biology. In 2020, he earned an MBA from Harvard Business School, graduating with High Distinction as a Baker Scholar. Scott previously worked at Ionis Pharmaceuticals in drug discovery and business development and at BioMarin Pharmaceuticals in pipeline commercialization.